Anti-CD20 B-cell depletion enhances monocyte reactivity in neuroimmunological disorders

被引：0
|
作者：
Lehmann-Horn, K. [1 ]
Schleich, E. [1 ]
Hertzenberg, D. [1 ]
Hapfelmeier, A. [1 ]
Kuempfel, T. [1 ]
von Bubnhoff, N. [1 ]
Hohlfeld, R. [1 ]
Berthele, A. [1 ]
Hemmer, B. [1 ]
Weber, M. S. [1 ]
机构：
[1] Tech Univ Munich, D-80290 Munich, Germany
来源：
MULTIPLE SCLEROSIS JOURNAL | 2011年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P1122
引用
收藏
页码：S519 / S519
页数：1
相关论文
共 50 条
  • [21] Regeneration of the immunoglobulin heavy-chain repertoire after transient B-cell depletion with an anti-CD20 antibody
    Rouzière, A
    Kneitz, C
    Palanichamy, A
    Dörner, T
    Tony, HP
    ARTHRITIS RESEARCH & THERAPY, 2005, 7 (04) : R714 - R724
  • [22] The efficacy and safety of B-cell depletion with anti-CD20 monoclonal antibody in adults with chronic immune thrombocytopenic purpura
    Cooper, N
    Stasi, R
    Cunningham-Rundles, SS
    Feuerstein, MA
    Leonard, JP
    Amadori, S
    Bussel, JB
    BRITISH JOURNAL OF HAEMATOLOGY, 2004, 125 (02) : 232 - 239
  • [23] Regeneration of the immunoglobulin heavy-chain repertoire after transient B-cell depletion with an anti-CD20 antibody
    Anne-Sophie Rouzière
    Christian Kneitz
    Arumugam Palanichamy
    Thomas Dörner
    Hans-Peter Tony
    Arthritis Research & Therapy, 7
  • [24] B-cell depletion and recovery after treatment with the anti-CD20 monoclonal antibody rituximab in patients with posttransplant lymphoproliferative disorders (PT-LPD).
    Grefer, J
    Oertel, SH
    Hummel, M
    Serke, S
    Reinke, P
    Jonas, S
    Anagnostopoulos, L
    Arnold, R
    Dörken, B
    Riess, H
    BLOOD, 2001, 98 (11) : 132A - 132A
  • [25] Anti-CD20 antibody mediated B cell depletion enhances viral control in SIV-infected rhesus macaques
    Fukazawa, Yoshi
    Lum, Richard
    Bae, Jin Young
    Ho, Alden
    Hansen, Scott
    Clock, Jeseph
    Randall, Bryan
    Park, Haesun
    Legasse, Alfred
    Axthelm, Michael
    Lifson, Jeffrey
    Okoye, Afam
    Picker, Louis
    JOURNAL OF MEDICAL PRIMATOLOGY, 2018, 47 (05) : 305 - 306
  • [26] BLOCKING B-CELLS (ANTI-CD20/ANTI-CD20)
    Isenberg, David A.
    RHEUMATOLOGY, 2015, 54 : 1 - 1
  • [27] Effects of anti-CD20 treatment beyond B cell depletion: Reduction of endogenous sTACI
    Mader, Simone
    Thaler, Franziska
    Fichtner, Miriam
    Ho, Samantha
    Oswald, Eva
    Wong, Hoi Kiu
    Vural, Atay
    Yilmaz, Vuslat
    Tuezuen, Erdem
    Turkoglu, Recai
    Straub, Tobias
    Smolle, Michalea
    Schaller, Jonas
    Feederle, Regina
    Bultmann, Andreas
    Schneider, Pascal
    Meinl, Ingrid
    Kuempfel, Tania
    Meinl, Edgar
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 592 - 593
  • [28] Variability in the biological response to anti-CD20 B cell depletion in systemic lupus erythaematosus
    Albert, D.
    Dunham, J.
    Khan, S.
    Stansberry, J.
    Kolasinski, S.
    Tsai, D.
    Pullman-Mooar, S.
    Barnack, F.
    Striebich, C.
    Looney, R. J.
    Prak, E. T. Luning
    Kimberly, R.
    Zhang, Y.
    Eisenberg, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2008, 67 (12) : 1724 - 1731
  • [29] B cell depletion by anti-CD20 antibodies entrains trabecular bone loss in mice
    Kolomansky, A.
    Deshet-Unger, N.
    Ostrovsky, A.
    Hiram-Bab, S.
    Ben-Califa, N.
    Liron, T.
    Oster, H. S.
    Mittelman, M.
    Gabet, Y.
    Neumann, D.
    FEBS JOURNAL, 2017, 284 : 141 - 141
  • [30] Clinical impact of B-cell depletion with the anti-CD20 antibody rituximab in chronic fatigue syndrome: a preliminary case series
    Øystein Fluge
    Olav Mella
    BMC Neurology, 9
12345